ARCHIVES

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

This article is from The Cancer Letter archive.

Vol. 03 No. 24 | June 17, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Lines Drawn Over HHS Appropriations.

October 5, 2007

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Garb’s Questions, Answers About Cancer Program

December 5, 1980

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007